# One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China

> **NCT04851457** · PHASE2 · COMPLETED · sponsor: **Shanghai East Hospital** · enrollment: 200 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Intravenous tirofiban combination therapy

## Key facts

- **NCT ID:** NCT04851457
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-06
- **Primary completion:** 2023-07-08
- **Final completion:** 2023-10-15
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04851457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04851457, "One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04851457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*